More than 9 out of 10 women undergoing in vitro fertilization (IVF) treatments at IVF-Life achieve pregnancy. These figures, which significantly exceed the European average, position this network of clinics as a reference center in reproductive medicine, especially for complex cases or after several failed attempts at other clinics.
In patients under 35 years, success rates reach 94% in conventional IVF and 98% when applying preimplantation genetic diagnosis (PGT), a technique that allows selecting chromosomally normal embryos before transfer. Even in women over 40 years, results remain extraordinarily high: 86% in IVF and 93% with PGT.
“Our goal is to accompany patients at every stage of the process with the best available means and a precision methodology that minimizes margins of error,” explains Dr. Llanos Medrano, national Laboratory Director of IVF-Life. “The combination of innovation, thorough control, and scientific knowledge allows us to offer results that make a difference,” she adds.
IVF-Life’s success relies on a clear strategy: integrating the latest scientific tools in every phase of the reproductive treatment. In the group’s laboratories, embryos develop under meticulously controlled conditions, ensuring their viability and maximizing implantation chances.
One pillar of this approach is the use of time-lapse incubators, which allow continuous real-time observation of embryo development without opening the incubators. This maintains stable temperature, humidity, and gas concentration levels essential for embryo evolution.
“Thanks to time-lapse technology, we can track embryo development minute by minute without disturbing the environment. This lets us identify embryos with optimal development and select the best to transfer,” Dr. Medrano details. “Continuous, interference-free observation reduces risks and increases pregnancy chances per attempt.”

The specialist also emphasizes that the key is not just having cutting-edge equipment but interpreting it correctly. “Technology gives us data, but the knowledge and experience of the team turn these data into right decisions. That’s why IVF-Life works with a multidisciplinary approach where embryologists, gynecologists, and geneticists collaborate closely,” she explains.
Another factor contributing to IVF-Life’s excellent results is rigorous laboratory quality control. Every variable—from room temperature to air quality—is continuously monitored to maintain a perfectly stable environment.
“The laboratory is the heart of a fertility clinic. Every detail counts,” Medrano says, adding that “we have an automated system that records environmental parameters 24/7. Even the slightest deviation is detected immediately.”
Additionally, the introduction of the SAGE 1-Step GM-CSF culture medium, designed to improve embryos’ physiological conditions, represents a decisive advance. Recently incorporated in IVF-Life labs, this medium increases success rates by up to 10% compared to traditional media by providing growth factors that enhance communication between embryo and uterine environment.
“This culture medium better replicates the natural conditions of the human body and improves implantation and pregnancy progression. In our lab, we’ve seen notable improvements, especially in patients with previous implantation failures or recurrent miscarriages,” the doctor points out.
Besides technical innovation, IVF-Life stands out for its human approach. Many women come to their clinics after long, frustrating treatment journeys. In this context, personalization and empathy are essential.
“Our commitment doesn’t end with the scientific part. We know there’s a personal story behind each case, so we adapt treatments to each patient’s circumstances and needs. Technology only makes sense if it helps achieve the goal of every person coming to our clinics,” assures Dr. Llanos Medrano.